Literature DB >> 14991835

Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis.

Alexander J Szalai1, Scott R Barnum.   

Abstract

Fcgamma receptors (FcgammaRs), composed of a ligand-binding alpha-chain (FcRalpha) sometimes associated with the homodimeric, cell-signaling common gamma-chain (FcRgamma), comprise an important family of effector molecules linking humoral and cell-mediated adaptive immunity and regulating innate immunity. In peripheral autoimmune diseases, FcgammaRs contribute to inflammation and tissue damage through inappropriate activation of macrophages and neutrophils, release of cytokines and oxidants, and destruction of autoantibody-opsonized cells. In the central nervous system (CNS), the role of FcgammaRs in autoimmune disease such as multiple sclerosis (MS) remains largely unexplored despite extensive documentation of CNS-specific antibodies in cerebrospinal fluid and plaques. Several studies have now examined the role of FcgammaRs in experimental autoimmune encephalomyelitis (EAE), the animal model for MS, using mice genetically deficient in one or more FcgammaRs or in FcRgamma. These studies indicate that none of the FcgammaR alpha-chains are critical for EAE development and progression. In contrast, it is unequivocal that FcRgamma contributes to EAE, and surprisingly it seems that this effect is independent of FcgammaRs. Recent studies now indicate that FcRgamma expression in gammadelta T cells, most likely as a component of the TCR/CD3 signaling complex, is a critical requirement for EAE development. These studies support previous evidence implicating a pathogenic role for gammadelta T cells in EAE. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991835     DOI: 10.1002/jnr.20023

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling.

Authors:  Daniel B Graham; Holly M Akilesh; Grzegorz B Gmyrek; Laura Piccio; Susan Gilfillan; Julia Sim; Roger Belizaire; Javier A Carrero; Yinan Wang; Gregory S Blaufuss; Gabriel Sandoval; Keiko Fujikawa; Anne H Cross; John H Russell; Marina Cella; Wojciech Swat
Journal:  Blood       Date:  2010-07-15       Impact factor: 22.113

Review 2.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

3.  Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent.

Authors:  Xian-Zhen Hu; Tyler T Wright; Nicholas R Jones; Theresa N Ramos; Gregory A Skibinski; Mark A McCrory; Scott R Barnum; Alexander J Szalai
Journal:  Autoimmune Dis       Date:  2010-10-12

4.  Microglial Fc receptors mediate physiological changes resulting from antibody cross-linking of myelin oligodendrocyte glycoprotein.

Authors:  Cecilia B Marta; Rashmi Bansal; Steven E Pfeiffer
Journal:  J Neuroimmunol       Date:  2008-04-11       Impact factor: 3.478

5.  Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collagen-induced arthritis by stimulating B cells.

Authors:  Toshio Kawamoto; Yoshiyuki Abe; Jun Ito; Fumihiko Makino; Yuko Kojima; Yoshihiko Usui; Juan Ma; Shinji Morimoto; Hideo Yagita; Ko Okumura; Yoshinari Takasaki; Hisaya Akiba
Journal:  Arthritis Res Ther       Date:  2011-03-22       Impact factor: 5.156

6.  Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis.

Authors:  David W Hampton; Andrea Serio; Gareth Pryce; Sarah Al-Izki; Robin Jm Franklin; Gavin Giovannoni; David Baker; Siddharthan Chandran
Journal:  Acta Neuropathol Commun       Date:  2013-12-23       Impact factor: 7.801

7.  Dual role for Fcγ receptors in host defense and disease in Borrelia burgdorferi-infected mice.

Authors:  Alexia A Belperron; Nengyin Liu; Carmen J Booth; Linda K Bockenstedt
Journal:  Front Cell Infect Microbiol       Date:  2014-06-11       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.